These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18288118)

  • 1. Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population.
    Wen SW; Yang T; Krewski D; Yang Q; Nimrod C; Garner P; Fraser W; Olatunbosun O; Walker MC
    J Perinatol; 2008 May; 28(5):324-9. PubMed ID: 18288118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population.
    Yang T; Walker MC; Krewski D; Yang Q; Nimrod C; Garner P; Fraser W; Olatunbosun O; Wen SW
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):270-7. PubMed ID: 18181228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to trimethoprim/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight.
    Yang J; Xie RH; Krewski D; Wang YJ; Walker M; Wen SW
    Int J Infect Dis; 2011 May; 15(5):e336-41. PubMed ID: 21345707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence and determinants of trimethoprim/sulfamethoxazole use in pregnancy.
    Yang T; Walker MC; Krewski D; Yang Q; Garner P; Fraser W; Olatunbosun O; Nimrod C; Wen SW
    Acta Obstet Gynecol Scand; 2007; 86(11):1310-6. PubMed ID: 17963058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription drug use in pregnancy.
    Andrade SE; Gurwitz JH; Davis RL; Chan KA; Finkelstein JA; Fortman K; McPhillips H; Raebel MA; Roblin D; Smith DH; Yood MU; Morse AN; Platt R
    Am J Obstet Gynecol; 2004 Aug; 191(2):398-407. PubMed ID: 15343213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between change of health care providers and pregnancy exposure to FDA category C, D and X drugs.
    Yang J; Xie R; Krewski D; Wang Y; Walker M; Cao W; Wen SW
    Chin Med J (Engl); 2014; 127(4):702-6. PubMed ID: 24534226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006).
    Daw JR; Mintzes B; Law MR; Hanley GE; Morgan SG
    Clin Ther; 2012 Jan; 34(1):239-249.e2. PubMed ID: 22169049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National patterns of medication use during pregnancy.
    Lee E; Maneno MK; Smith L; Weiss SR; Zuckerman IH; Wutoh AK; Xue Z
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):537-45. PubMed ID: 16700083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nongenital malformations following exposure to progestational drugs: the last chapter of an erroneous allegation.
    Brent RL
    Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):906-18. PubMed ID: 16206282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of prescription medications with a potential for fetal harm among pregnant women.
    Andrade SE; Raebel MA; Morse AN; Davis RL; Chan KA; Finkelstein JA; Fortman KK; McPhillips H; Roblin D; Smith DH; Yood MU; Platt R; H Gurwitz J
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):546-54. PubMed ID: 16586470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antirheumatic drugs in mothers and fathers before and during pregnancy-a population-based cohort study.
    Viktil KK; Engeland A; Furu K
    Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):737-42. PubMed ID: 19504626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands.
    Bakker MK; Jentink J; Vroom F; Van Den Berg PB; De Walle HE; De Jong-Van Den Berg LT
    BJOG; 2006 May; 113(5):559-68. PubMed ID: 16637899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system.
    Schirm E; Meijer WM; Tobi H; de Jong-van den Berg LT
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):182-8. PubMed ID: 15140513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Content and format of labeling for human prescription drugs; pregnancy labeling; public hearing--FDA. Notice of public hearing; request for comments.
    Fed Regist; 1997 Jul; 62(147):41061-3. PubMed ID: 10169832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of drug use among pregnant women in Addis Ababa, Ethiopia.
    Kebede B; Gedif T; Getachew A
    Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):462-8. PubMed ID: 19334033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of data for 10 children born to mothers who attempted suicide by taking large doses of alprazolam during pregnancy.
    Gidai J; Acs N; Bánhidy F; Czeizel AE
    Toxicol Ind Health; 2008; 24(1-2):53-60. PubMed ID: 18818181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription of medications during pregnancy: accidents, compromises, and uncertainties.
    Hernández-Díaz S
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):613-7. PubMed ID: 16941520
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drugs during pregnancy and breastfeeding: new risk categories--antibiotics as a model].
    Bertsche T; Haas M; Oberwittler H; Haefeli WE; Walter-Sack I
    Dtsch Med Wochenschr; 2006 May; 131(18):1016-22. PubMed ID: 16673226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA boxed warnings: how to prescribe drugs safely.
    O'Connor NR
    Am Fam Physician; 2010 Feb; 81(3):298-303. PubMed ID: 20112888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes.
    Taguchi N; Rubin ET; Hosokawa A; Choi J; Ying AY; Moretti ME; Koren G; Ito S
    Reprod Toxicol; 2008 Oct; 26(2):175-7. PubMed ID: 18640262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.